���存条件与分析表征方法 — Reference Sheet

By Editorial Desk · published 2025-09-23 · last reviewed 2025-10-16 · Topic

The short version of GLP-1 fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-10-16 and is reviewed periodically as new material appears.

储存条件与分析表征方法

肽类的主要降解路径包括天冬酰胺脱酰胺、甲硫氨酸氧化、天冬氨酸异构化以及由 β-折叠驱动的聚集，这些反应对 pH 与缓冲液种类较为敏感。磷酸盐、丙二醇与苯酚等辅料会影响局部微环境与界面行为。强制降解研究借助高温、强光、氧化剂与极端 pH 暴露来预测产物谱。关于长期室温存放的数据相对有限，超出标签条件的稳定性仍属开放问题，需要在具体制剂中通过实时与加速试验加以确认。

容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。

关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。

Semaglutide Background and Drug Class

GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.

Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.

Semaglutide at a glance

Background and Receptor Mechanism

Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.

Related pages on this site

• Quality summary
• Scalable toolkit
• Lightweight analysis
• Adaptive playbook
• Professional toolkit
• Automated archive
• Efficient checklist
• Efficient dataset

Molecular Background and Drug Class

Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.

Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.

Reference notes

Nicotinamide is recommended as a treatment for niacin deficiency because it can be administered in remedial amounts without causing the flushing, considered an adverse effect. In the past, the group was loosely referred to as vitamin B3 complex. Extra-terrestrial nicotinic acid and nicotinamide have been detected in carbonaceous chondrite meteorites and in sample-returns from the asteroids 162173 Ryugu and 101955 Bennu.

The research, as cited by the cover story of the November 2005 issue of National Geographic, asserts that Adventists live longer because they do not smoke or drink alcohol, have a day of rest every week, and maintain a healthy, low-fat vegetarian diet that is rich in nuts and beans. The cohesiveness of Adventists' social networks has also been put forward as an explanation for their extended lifespan. Since Dan Buettner's 2005 National Geographic story about Adventist longevity, his book, The Blue Zones: Lessons for Living Longer From the People Who've Lived the Longest, named Loma Linda, California, a "blue zone" because of the large concentration of Seventh-day Adventists. He cites the Adventist emphasis on health, diet, and Sabbath-keeping as primary factors for Adventist longevity. An estimated 35% of Adventists practice vegetarianism or veganism, according to a 2002 worldwide survey of local church leaders. North American Adventist health study recruitments from 2001 to 2007 found a similar prevalence of vegetarianism/veganism. A small majority of Adventists, 54%, were conventional meat-eaters. Of the remaining 46% it was found that 28% were Ovo/Lacto-vegetarians, 10% were Pesco-vegetarians and 8% were vegans. It is common for Adventists who choose to eat meat to also eat plant-based foods; 6% of the "meat-eaters" group restricted their intake of meat/fish to no more than once per week.

The last scene of the commercial showed Ivana asking for the last slice, to which Donald replied, "Actually, you're only entitled to half", a play on the couple's recent divorce. In 1995, Ringo Starr appeared in a Pizza Hut commercial that teased to a Beatles reunion, but featured three members of the Monkees. A commercial with Rush Limbaugh dates from the same year, in which he boasts "nobody is more right than me", yet he states for the first time he will do something wrong, which was to participate in Pizza Hut's then "eating pizza crust first" campaign regarding their stuffed crust pizzas. In 1999, the announcer says, "The best pizzas under one roof" in the Big New Yorker pizza commercial seen on the PlayStation Pizza Hut Demo Disc 1. Also, in 1999, the game Crazy Taxi for the Dreamcast featured Pizza Hut as one of the locations to which players were able to drive and drop off customers. However, in the game's 2010 re-release for Xbox Live and PlayStation Network, all of the product placement, including the Pizza Hut locations, were removed and replaced with generic locations. Early 2007 had Pizza Hut move into several more interactive ways of marketing to the consumer. Using mobile-phone SMS technology and their MyHut ordering site, they aired several television commercials (commencing just before the Super Bowl) containing hidden words that viewers could type into their phones to receive coupons.

== Treatment == Treatment is dependent on the type of glycogen storage disease. Von Gierke disease (GSD-I) is typically treated with frequent small meals of carbohydrates and cornstarch, called modified cornstarch therapy, to prevent low blood sugar, while other treatments may include allopurinol and human granulocyte colony stimulating factor. Cori/Forbes disease (GSD-III) treatment may use modified cornstarch therapy, a high protein diet with a preference to complex carbohydrates. However, unlike GSD-I, gluconeogenesis is functional, so simple sugars (sucrose, fructose, and lactose) are not prohibited. A ketogenic diet has demonstrated beneficial for McArdle disease (GSD-V) as ketones readily convert to acetyl CoA for oxidative phosphorylation, whereas free fatty acids take a few minutes to convert into acetyl CoA. For phosphoglucomutase deficiency (formerly GSD-XIV), D-galactose supplements and exercise training has shown favourable improvement of signs and symptoms. In terms of exercise training, some patients with phosphoglucomutase deficiency also experience "second wind." For McArdle disease (GSD-V), regular aerobic exercise utilizing "second wind" to enable the muscles to become aerobically conditioned, as well as anaerobic exercise (strength training) that follows the activity adaptations so as not to cause muscle injury, helps to improve exercise intolerance symptoms and maintain overall health.

Sources: en.wikipedia.org

Notes from published material

== Tissue distribution == CRF1 is expressed widely throughout both the central and peripheral nervous systems. In the central nervous system, CRF1 is particularly found in the cortex, cerebellum, amygdala, hippocampus, olfactory bulb, ventral tegmental area, brainstem areas, paraventricular hypothalamus, and pituitary. In the pituitary, CRF1 stimulation triggers the activation of the POMC gene, which in turn causes the release of ACTH and β-endorphins from the anterior pituitary. In the peripheral nervous system, CRF1 is expressed at low levels in a wide variety of tissues, including the skin, spleen, heart, liver, adipose tissue, placenta, ovary, testis, and adrenal gland. In CRF1 knockout mice, and mice treated with a CRF1 antagonist, there is a decrease in anxious behavior and a blunted stress response, suggesting that CRF1 mechanisms are anxiogenic. However, the effect of CRF1 appears to be regionally specific and cell-type specific, likely due to the wide variety of cascades and signaling pathways activated by the binding of CRF or CRF-agonists. In mice, offspring born to CRF1 -/- knockout mothers typically die within a few days of birth from lung dysplasia, likely due to low glucocorticoid levels. In the central nervous system, CRF1 activation mediates fear learning and consolidation in the extended amygdala, stress-related modulation of memory formation in the hippocampus, and brainstem regulation of arousal.

== List of hosts == Amur Cossack Host (1860–1918) Astrakhan Cossack Host (1737–1920) Azov Cossack Host (1832–1862) Baikal Cossack Host (1851-1920) Bashkir Host (1798-1865) Black Sea Cossack Host (1787–1864) Buh Cossack Host (1769–1817) Caucasus Line Cossack Host (1832–1860) Danube Cossack Host (1828–1868), an Imperial Russian Cossack Host formed from descendants of the Zaporozhian Cossacks Don Cossack Host (1570-1918, reconstituted in 1992) Greben Cossacks Host (1711–1745–1845-60–1920, reconstituted in 1992) Kuban Cossack Host (1860–1920, reconstituted in 1992) Orenburg Cossack Host (1755–1920) Semiryechye Cossack Host (1867–1920) Siberian Cossack Host (1582-1918) Terek Cossack Host (1577–1792–1860–1920, reconstituted in 1992) Transbaikal Cossack Host (1851–1920) Ural Cossack Host (c. 14th century-end–1920) Ussuri Cossack Host (1889–1922, re-established in 1990) Volga Cossack Host (1734–1777) Zaporozhian Host (1572/1649–1775), of the Zaporozhian Cossacks who lived in Zaporizhia, Dnieper Ukraine, during the 16th — 18th centuries.

=== Dust explosions === Pyrite oxidation is sufficiently exothermic that underground coal mines in high-sulfur coal seams have occasionally had serious problems with spontaneous combustion. The solution is the use of buffer blasting and the use of various sealing or cladding agents to hermetically seal the mined-out areas to exclude oxygen. In modern coal mines, limestone dust is sprayed onto the exposed coal surfaces to reduce the hazard of dust explosions. This has the secondary benefit of neutralizing the acid released by pyrite oxidation and therefore slowing the oxidation cycle described above, thus reducing the likelihood of spontaneous combustion. In the long term, however, oxidation continues, and the hydrated sulfates formed may exert crystallization pressure that can expand cracks in the rock and lead eventually to roof fall.

=== Match schedule === The match schedule, without group assignments, was announced on February 4, 2024. On June 13, FIFA released an updated schedule, with specific pairings assigned to venues for the knockout stage. The full schedule was unveiled in a live broadcast on December 6, 2025, the day after the draw. The opening match of the tournament included Mexico, and took place on June 11, 2026, at the Estadio Azteca in Mexico City. Canada's first match occurred on June 12 at BMO Field in Toronto, while the United States' opening match took place on the same day at SoFi Stadium in Inglewood. The national team of each host nation played its three group stage matches in its own country. AT&T Stadium in Arlington hosted the most matches of any venue, with nine. The U.S. hosted 78 matches, including all quarterfinals, semifinals, and the final, which was played at MetLife Stadium in East Rutherford on July 19. Canada and Mexico each hosted 13 matches. Each tournament venue, except for the Estadio Akron, hosted at least one knockout stage match. The match schedule overlapped with the 2026 Canadian Football League season, resulting in scheduling conflicts and loss of home games for the Toronto Argonauts and BC Lions. The match schedule also affected the 2026 Major League Baseball season schedules of the Kansas City Royals, Philadelphia Phillies, Seattle Mariners, and Texas Rangers, with home stadiums near World Cup venues. Host cities were geographically grouped into three regions:

== Proteomics == SRM can be used for targeted quantitative proteomics by mass spectrometry. Following ionization in, for example, an electrospray source, a peptide precursor is first isolated to obtain a substantial ion population of mostly the intended species. This population is then fragmented to yield product ions whose signal abundances are indicative of the abundance of the peptide in the sample. This experiment can be performed on triple quadrupole mass spectrometers, where mass-resolving Q1 isolates the precursor, q2 acts as a collision cell, and mass-resolving Q3 is cycled through the product ions which are detected upon exiting the last quadrupole by an electron multiplier. A precursor/product pair is often referred to as a transition. Much work goes into ensuring that transitions are selected that have maximum specificity. Using isotopic labeling with heavy-labeled (e.g., D, 13C, or 15N) peptides to a complex matrix as concentration standards, SRM can be used to construct a calibration curve that can provide the absolute quantification (i.e., copy number per cell) of the native, light peptide, and by extension, its parent protein.

Sources: en.wikipedia.org

Background from the literature

At the Villejuif Mental Hospital in November 1951, he and Montassut administered an intravenous dose to psychiatrist Cornelia Quarti, who was acting as a volunteer. Quarti noted the indifference but fainted upon getting up to go to the toilet, and so further testing was discontinued. (Orthostatic hypotension is a known side effect of chlorpromazine). Despite this, Laborit continued to push for testing in psychiatric patients during early 1952. Psychiatrists were reluctant initially, but on 19 January 1952, it was administered (alongside pethidine, pentothal and ECT) to Jacques Lh., a 24-year-old manic patient, who responded dramatically; he was discharged after three weeks, having received 855 mg of the drug in total. Pierre Deniker had heard about Laborit's work from his brother-in-law, who was a surgeon, and ordered chlorpromazine for a clinical trial at the Sainte-Anne Hospital Center in Paris where he was chief of the men's service. Together with the hospital director Jean Delay, they published their first clinical trial in 1952, in which they treated thirty-eight psychotic patients with daily injections of chlorpromazine without the use of other sedating agents. The response was dramatic; treatment with chlorpromazine went beyond simple sedation, with patients showing improvements in thinking and emotional behaviour. They also found that doses higher than those used by Laborit were required, giving patients 75–100 mg daily.

== Deaths == 18 January – Sir David Cox, English statistician (b. 1924) 15 March – Eugene Parker, American solar and plasma physicist (b. 1927) 20 March – Wen Shengchang, Chinese oceanographer and member of the Chinese Academy of Sciences (b. 1921) 23 March – Arthur Riggs, American geneticist (b. 1939) 27 March – Martin Pope, American physical scientist (b. 1918) 27 March – James Vaupel, American demographer and aging researcher (b. 1945) 29 March – Paul Benioff, American physicist of quantum computing (b. 1930) 30 March – Kenneth Walters, British mathematician and rheologist (b. 1934) 1 April – Gerhard J. Woeginger, Austrian mathematician. 5 April – Sidney Altman, Canadian-American molecular biologist, Nobel Prize laureate (1989). 5 April – Bjarni Tryggvason, Icelandic-born Canadian astronaut (STS-85). 5 April – Eelco Visser, Dutch computer scientist. 5 April – Leslie Young, New Zealand economist. 1 May – Ray Freeman, British chemist. 1 May – Dominique Lecourt, French philosopher. 2 May – Joseph Raz, Israeli philosopher. 4 May – Amanda Claridge, Canadian archaeologist. 7 May – Sir Paul Mellars, British archaeologist. 8 May – Harry Dornbrand, American aerospace engineer. 8 May – Zhuang Qiaosheng, Chinese geneticist and wheat breeder, member of the Chinese Academy of Sciences. 9 May – John H. Coates, Australian mathematician. 14 May – Bernard Bigot, French physicist and civil servant, director general of ITER (b. 1950) 9 June – Gordon M. Shepherd, American neuroscientist. 26 July – James Lovelock, English environmentalist (Gaia hypothesis) and futurist (b.

== Function == The protein encoded by this gene belongs to the family of G-protein coupled receptors that are preferentially activated by adenosine and uridine nucleotides. Two alternatively spliced transcript variants encoding the same protein isoform have been found for this gene.

=== Pathophysiological models === Clinical professionals continue to debate the causes of spontaneous upper airway blockage. The areas of thought are divided mostly into three medical groups. Some pulmonologists and neurologists believe the risk factors to be:

The Fascial Net Plastination Project (FNPP) is an anatomical research initiative led by fascia researcher Robert Schleip. The project aims to enhance the study of fascia through the technique of plastination. Led by an international team of fascia experts and anatomists, the FNPP resulted in the creation of a full-body fascia plastinate known as FR:EIA (Fascia Revealed: Educating Interconnected Anatomy). This plastinate provides a detailed view of the human fascial network, allowing for a better understanding of its structure and function as an interconnected tissue throughout the body. FR:EIA was unveiled at the 2021 Fascia Research Congress and is currently exhibited at the Body Worlds exhibition in Berlin. This project represents a significant contribution to the visualization of fascia and has the potential to influence future research in fields such as medicine, physical therapy, and movement science.

Sources: en.wikipedia.org

Frequently asked questions